Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acyclovir: A Decade Later

10 Sept 1992

Abstract excerpt

REPORTS of the clinical efficacy of acyclovir, a selective and specific inhibitor of herpesvirus replication, appeared in the literature a decade ago. Acyclovir has become the most widely prescribed and clinically effective antiviral drug available, and research on new indications is ongoing. This review will summarize our current understanding of the indications as well as the limitations of acyclovir...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to Toxin Mechanisms and Immunotoxins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 1288525
DOI: 10.1056/nejm199209103271108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acyclovir: A Decade LaterPMID 1288525Read ↗

Acyclovir: Discovery, mechanism of action, and selectivitySemantic proximity Read ↗

Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human TissuesSemantic proximity Read ↗

Cidofovir, a New Agent with Potent Anti-Herpesvirus ActivitySemantic proximity Read ↗

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.Semantic proximity Read ↗

Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.Semantic proximity Read ↗

Helicase‐Primase as a Target of New Therapies for Herpes Simplex Virus InfectionsSemantic proximity Read ↗

Acyclovir-resistant, pathogenic herpesviruses.Semantic proximity Read ↗

Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment RegimensSemantic proximity Read ↗

LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against HerpesvirusesSemantic proximity Read ↗

Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.Semantic proximity Read ↗

The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.Semantic proximity Read ↗

Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.